Subunit characterization of NMDA receptors.

Abstract:

:NMDA receptors are a subclass of excitatory, ionotropic L-glutamate neurotransmitter receptors. They are.heteromeric, integral membrane proteins being formed by the assembly of the obligatory NR1 subunit together with modulatory NR2 subunits of which four different types, NR2A-NR2D, have been described. This results in a heterogenous population of receptor proteins with distinct pharmacological and biophysical properties thus yielding potential for the development of NMDA receptor subtype-selective therapeutic agents. Anti-NMDA receptor subunit antibodies have been generated and used in immunoprecipitation or immunoaffinity purification studies to determine the in vivo subunit complements of NMDA receptors. This article summarizes knowledge on the subunit compositions of NMDA receptors based on these approaches together with the current status of NMDA receptor subunit stoichiometry and hence quaternary structure. of native NMDA receptors.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Stephenson FA

doi

10.2174/1389450013348461

keywords:

subject

Has Abstract

pub_date

2001-09-01 00:00:00

pages

233-9

issue

3

eissn

1389-4501

issn

1873-5592

journal_volume

2

pub_type

杂志文章,评审
  • Alternatives to conventional vaccines--mediators of innate immunity.

    abstract::Vaccines have been described as "weapons of mass protection". The eradication of many diseases is testament to their utility and effectiveness. Nevertheless, many vaccine preventable diseases remain prevalent because of political and economic barriers. Additionally, the effects of immaturity and old age, therapies tha...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043490703

    authors: Eisen DP,Liley HG,Minchinton RM

    更新日期:2004-01-01 00:00:00

  • Adaptors in toll-like receptor signaling and their potential as therapeutic targets.

    abstract::To initiate the innate immune response, Toll-like receptors (TLRs) associate with cytoplasmic adaptor proteins through TIR (Toll/interleukin-1 receptor) domain interactions. The four principal signaling adaptor proteins include MyD88, MAL, TRIF and TRAM, and the fifth protein SARM, involved in negative regulation of T...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012803530260

    authors: Ve T,Gay NJ,Mansell A,Kobe B,Kellie S

    更新日期:2012-10-01 00:00:00

  • Fluoroquinolones: Blessings Or Curses.

    abstract::Fluoroquinolones are one of the world's most valuable and popularly used categories of antimicrobial agents. This paper attempts to review the substantial progress of fluoroquinolones from their discovery to black box warning. Antibiotic drug choice will remain difficult in the presence of increasing resistance, but t...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200621193355

    authors: Majalekar PP,Shirote PJ

    更新日期:2020-01-01 00:00:00

  • The deficit in low molecular weight thiols as a target for antiageing therapy.

    abstract::The popular use of antioxidative vitamins illustrates the growing awareness of oxidative stress as an important hazard to our health and as an important factor in the ageing process. Superoxide radicals and superoxide-derived reactive oxygen species (ROS) are constantly formed in most cells and tissues. To ensure that...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450110607011505

    authors: Dröge W,Kinscherf R,Hildebrandt W,Schmitt T

    更新日期:2006-11-01 00:00:00

  • TGF-betal/Smad signaling in prostate cancer.

    abstract::Adenocarcinoma of the prostate is the most common type of cancer, excluding skin cancer, and the second leading cause of cancer death in adult men in the United States. The lifetime risk for developing symptomatic prostate cancer is one in five for an American man. A pivotal step in carcinogenesis is a shift in the ba...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033491118

    authors: Bello-DeOcampo D,Tindall DJ

    更新日期:2003-04-01 00:00:00

  • Diacylglycerol kinases as emerging potential drug targets for a variety of diseases.

    abstract::Diacylglycerol (DAG) kinase (DGK) modulates the balance between the two signaling lipids, DAG and phosphatidic acid (PA), by phosphorylating (consuming) DAG to yield PA. Ten mammalian DGK isozymes have been identified to date. In addition to two or three cysteine-rich C1 domains (protein kinase C-like zinc finger stru...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008785132394

    authors: Sakane F,Imai S,Kai M,Yasuda S,Kanoh H

    更新日期:2008-08-01 00:00:00

  • Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents.

    abstract::The recent marketing of two selective cyclooxygenase-2 (COX-2) inhibitors, celecoxib and rofecoxib is remarkable considering that COX-2 was only discovered eight years ago as a growth factor- and cytokine-inducible gene. Concomitant with these pharmaceutical successes is the advances in our understanding of the molecu...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450013348830

    authors: Kalgutkar AS,Zhao Z

    更新日期:2001-03-01 00:00:00

  • MicroRNAs in arterial remodelling, inflammation and atherosclerosis.

    abstract::Atherosclerosis is now widely appreciated to represent a chronic inflammatory reaction of the vascular wall in response to dyslipidemia and endothelial distress involving the inflammatory recruitment of leukocytes and the activation of resident vascular cells. The proliferative response of smooth muscle cells critical...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010791591377

    authors: Weber C,Schober A,Zernecke A

    更新日期:2010-08-01 00:00:00

  • Searching for novel cancer chemopreventive plants and their products: the genus Zanthoxylum.

    abstract::The genus Zanthoxylum (Rutaceae) comprises about 250 species, of which many are used as food, often as condiments, substituting pepper due to the pungent taste of fruits, seeds, leaves, and bark, and therapeutic remedies especially in Eastern Asian countries and in Central America. The whole plant is also consumed as ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011798184128

    authors: Epifano F,Curini M,Marcotullio MC,Genovese S

    更新日期:2011-12-01 00:00:00

  • Vascular disrupting agents (VDA) in oncology: advancing towards new therapeutic paradigms in the clinic.

    abstract::Vascular Disrupting Agents (VDA) are a potential new class of oncology drugs that have garnered attention recently as a number of these agents have entered into Phase 2-3 studies. Currently available data suggest how the subsequent evolution of these agents into clinical practice may proceed, with new therapeutic para...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011798829366

    authors: Spear MA,LoRusso P,Mita A,Mita M

    更新日期:2011-12-01 00:00:00

  • From "An Enzyme Able to Destroy Penicillin" to Carbapenemases: 70 Years of Beta-lactamase Misbehaviour.

    abstract::As early as 1940, Abraham and Chain described "an enzyme able to destroy penicillin". In the late 1940's, penicillin-resistant strains of Staphylococcus aureus were found to be a clinical problem. They produced a penicillinase that could hydrolyze the amide bond in the β-lactam ring. Later, an enzyme mediated by an R-...

    journal_title:Current drug targets

    pub_type: 历史文章,杂志文章,评审

    doi:10.2174/1389450116666151001112859

    authors: Frère JM,Sauvage E,Kerff F

    更新日期:2016-01-01 00:00:00

  • Targeting calcium and the mitochondria in prevention of pathology in the heart.

    abstract::Calcium is a key determinant of cardiac excitation, contraction and relaxation. Cardiac excitation and contraction is powered by ATP that is synthesized within mitochondria via a calcium-dependent process known as oxidative phosphorylation. During this process oxygen molecules within the mitochondria are converted to ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011795378603

    authors: Viola HM,Hool LC

    更新日期:2011-05-01 00:00:00

  • Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

    abstract::Novel anti-vasculature strategies that are emerging for the treatment of cancer and for the inhibition of angiogenesis may be a promising new tool for the adjuvant therapy of malignant tumours. Over the last fifteen years, several reports have been published concerning the relationship between tumour progression and a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009789577954

    authors: Pastorino F,Di Paolo D,Loi M,Becherini P,Caffa I,Zorzoli A,Marimpietri D,Carosio R,Perri P,Montaldo PG,Brignole C,Pagnan G,Ribatti D,Allen TM,Ponzoni M

    更新日期:2009-10-01 00:00:00

  • Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.

    abstract::Overexpression of the human epidermal growth factor receptor 2 (HER2) is identified in approximately 25- 30% of breast cancers and indicates a poor prognosis. Trastuzumab, the anti-HER2 monoclonal antibody (mAb), has shown significant clinical effects selectively in HER2-overexpressing metastatic breast cancer (MBC) w...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990161

    authors: Huang Y,Fu P,Fan W

    更新日期:2013-07-01 00:00:00

  • Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfuntion.

    abstract::Flavonoids are chromene analogues abundantly found in plants. It is always of curiosity to discover natural flavonoid structures, since living things, including human, are routinely exposed to these compounds through many dietaries. Indeed, numerous studies conducted so far on flavonoids to display their diverse biolo...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450122666210120144921

    authors: Gulcan HO,Orhan IE

    更新日期:2021-01-20 00:00:00

  • Drug-binding databases.

    abstract::Recent developments in computer power and chemoinformatics methodology make possible that a huge amount of data become available through internet. These databases are devoted to a wide spectrum of scientific fields. Here we are concerned with databases related to protein-drug interactions. More specifically, databases...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008786949379

    authors: Timmers LF,Pauli I,Caceres RA,de Azevedo WF Jr

    更新日期:2008-12-01 00:00:00

  • Autophagy: A Promising Target for Age-related Osteoporosis.

    abstract::Autophagy is a process the primary role of which is to clear up damaged cellular components such as long-lived proteins and organelles, thus participating in the conservation of different cells. Osteoporosis associated with aging is characterized by consistent changes in bone metabolism with suppression of bone format...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450119666180626120852

    authors: Wang T,He H,Liu S,Jia C,Fan Z,Zhong C,Yu J,Liu H,He C

    更新日期:2019-01-01 00:00:00

  • Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.

    abstract::The development of novel T cell therapies to target leukemia has facilitated the translation of this approach for hematologic malignancies. Different methods of manufacturing leukemia-specific T cells have evolved, along with additional measures to increase the safety of this therapy. This is an overview of expanded T...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160209143529

    authors: Cruz CR,Bollard CM

    更新日期:2017-01-01 00:00:00

  • Improving the embryo implantation via novel molecular targets.

    abstract::With the development of modern assisted reproductive technology(ART), the treatment of infertility and the pregnant outcome by ART have been significantly improved. However, implantation failure, particularly the unexplained repeated implantation failure (RIF), is still the unsolved and principal problem to affect the...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314080006

    authors: Li J,Liang X,Chen Z

    更新日期:2013-07-01 00:00:00

  • Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances.

    abstract::Newer classes of medications have been proven useful in glycemic control in type 2 diabetes (T2D), but many do not appear capable to slow down the progressive loss of ß-cell function, or to improve population-level glycemic control. Positive energy balance, e.g. surplus energy intake over expenditure, is at the core f...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666181217111500

    authors: Liu Z,Yang B

    更新日期:2019-01-01 00:00:00

  • Metal and inflammatory targets for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) has become linked to inflammation and metal biology. Metals (copper, zinc and iron) and inflammatory cytokines are significant factors that increase the onset of sporadic late onset forms of the dementia. The genetic discovery that alleles in the hemochromatosis gene accelerate the onset of di...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345272

    authors: Rogers JT,Lahiri DK

    更新日期:2004-08-01 00:00:00

  • microRNAs: innovative targets for cerebral ischemia and stroke.

    abstract::Stroke is one of the leading causes of death and disability worldwide. Because stroke is a multifactorial disease with a short therapeutic window many clinical stroke trials have failed and the only currently approved therapy is thrombolysis. MicroRNAs (miRNA) are endogenously expressed noncoding short single-stranded...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945013804806424

    authors: Ouyang YB,Stary CM,Yang GY,Giffard R

    更新日期:2013-01-01 00:00:00

  • Mitochondrial drug targets in apicomplexan parasites.

    abstract::In evolutionary terms, mitochondria in apicomplexan parasites appear to be "relicts-in-the-making": they possess the smallest mitochondrial genomes known, encoding only three proteins, and in one genus, Cryptosporidium, the genome is eliminated altogether. Several features of mitochondrial physiology provide validated...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779315632

    authors: Mather MW,Henry KW,Vaidya AB

    更新日期:2007-01-01 00:00:00

  • Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

    abstract::Retinal neovascularization and macular edema are central features of diabetic retinopathy, a major cause of blindness in working age adults. The currently established treatment for diabetic retinopathy targets the vascular pathology by laser photocoagulation. This approach is associated with significant adverse effect...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054021981

    authors: Caldwell RB,Bartoli M,Behzadian MA,El-Remessy AE,Al-Shabrawey M,Platt DH,Liou GI,Caldwell RW

    更新日期:2005-06-01 00:00:00

  • Regulation of thrombospondin1 by extracellular proteases.

    abstract::The contribution of proteases to developmental, physiological and pathological processes has been well accepted. Cleavage of matrix proteins is a key requirement for cell migration and remodeling of the extracellular environment. The constant process of matrix turnover is dependent on the delicate balance between degr...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008785909365

    authors: Iruela-Arispe ML

    更新日期:2008-10-01 00:00:00

  • Three-Dimensional Manufactured Supports for Breast Cancer Stem Cell Population Characterization.

    abstract::Breast Cancer (BC) is the most common cancer among women and the second cause of female death for cancer. When the tumor is not correctly eradicated, there is a high relapse risk and incidence of metastasis. Breast Cancer Stem Cells (BCSCs) are responsible for initiating tumors and are resistant to current anticancer ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666181122113300

    authors: Polonio-Alcalá E,Rabionet M,Ruiz-Martínez S,Ciurana J,Puig T

    更新日期:2019-01-01 00:00:00

  • Gene therapy for arthritis.

    abstract::Recent progress in molecular biology has provided application of gene transfer methods in arthritis. Two clinical trails using ex vivo retrovirus mediated delivery of interleukin -1 receptor antagonist gene for rheumatoid arthritis has begun in USA and Germany. However, there are still many issues to be elucidated; on...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033490777

    authors: Tomita T,Hashimoto H,Yoshikawa H

    更新日期:2003-11-01 00:00:00

  • Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review.

    abstract::Due to potential health benefits and the general assumption that natural products are safe, there is an increasing trend in the general population - including pregnant women - to supplement their diet with flavonoid-based food supplements. In addition, preclinical studies aim to prevent developmental adverse effects i...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150804110049

    authors: Barenys M,Masjosthusmann S,Fritsche E

    更新日期:2017-01-01 00:00:00

  • Multidrug transporters as drug targets.

    abstract::Transport molecules can significantly affect the pharmacodynamics and pharmacokinetics of drugs. An important transport molecule, the 170 kDa P-glycoprotein (Pgp), is constitutively expressed at several organ sites in the human body. Pgp is expressed at the blood-brain barrier, in the kidneys, liver, intestines and in...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778019264

    authors: Liang XJ,Aszalos A

    更新日期:2006-08-01 00:00:00

  • Molecular pathology of pancreatic cancer: from bench-to-bedside translation.

    abstract::Pancreatic ductal adenocarcinoma (referred here as pancreatic cancer) is a lethal disease with the worst prognosis among all solid tumors. Surgical resection represents the only hope for cure but it is possible only in patients that present with local disease (about 20% of cases). Whether dismal prognosis of pancreati...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012800564103

    authors: Corbo V,Tortora G,Scarpa A

    更新日期:2012-06-01 00:00:00